PHARMACOKINETICS AND TOXICITY OF 2ND LINE ANTI-TB DRUGS IN HIV-INFECTED CHILDREN

Pascale Willem

The Coding Genome Of HIV-Associated Plasmablastic Lymphomas In South Africa

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Leona W Ayers

Mid-Region Aids and Cancer Specimen Resource Consortium

Hodgkin lymphoma Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Scott Durum

Cytokines and T Cell Development

Non-Hodgkin lymphoma Leukaemia

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies

Robert W. Coombs

Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri

Ju-Seog Lee

Hippo Pathway in Hepatocellualr Carcinoma

Liver and intrahepatic bile ducts

Pathology

Ethel Cesarman

Modeling KSHV latency in vivo

Kaposi sarcoma

Frank Gonzalez

Xenobiotic Receptors – Rockville

Liver and intrahepatic bile ducts

Pathology

David Price

The immunopathogenesis of Epstein-Barr virus-associated malignancies.

Non-Hodgkin lymphoma

Pathology